New Mexico 2025 Regular Session

New Mexico House Bill HB505 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	underscored material = new
2	2	[bracketed material] = delete
3	3	1
4	4	2
5	5	3
6	6	4
7	7	5
8	8	6
9	9	7
10	10	8
11	11	9
12	12	10
13	13	11
14	14	12
15	15	13
16	16	14
17	17	15
18	18	16
19	19	17
20	20	18
21	21	19
22	22	20
23	23	21
24	24	22
25	25	23
26	26	24
27	27	25
28	28	HOUSE BILL 505
29	29	57
30	30	TH LEGISLATURE
31	31	-
32	32
33	33	STATE
34	34
35	35	OF
36	36
37	37	NEW
38	38
39	39	MEXICO
40	40
41	41	-
42	42	FIRST SESSION
43	43	,
44	44
45	45	2025
46	46	INTRODUCED BY
47	47	Cristina Parajón and Antoinette Sedillo Lopez
48	48	AN ACT
49	49	RELATING TO OPIOIDS; REQUIRING RETAIL PHARMACIES TO KEEP STOCKS
50	50	OF CERTAIN TYPES OF DRUGS THAT TREAT OPIOID USE DISORDER;
51	51	REQUIRING WHOLESALE DRUG DISTRIBUTORS TO REPORT INSTANCES IN
52	52	WHICH THE DISTRIBUTORS DO NOT FILL ORDERS FOR BUPRENORPHINE
53	53	MADE BY RETAIL PHARMACIES; REQUIRING REPORTS; PROVIDING
54	54	PENALTIES.
55	55	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:
56	56	SECTION 1. A new section of the New Mexico Drug, Device
57	57	and Cosmetic Act is enacted to read:
58	58	"[NEW MATERIAL] BUPRENORPHINE STOCKING REQUIREMENTS.--
59	59	A. At least once every thirty days, each retail
60	60	pharmacy that stocks controlled substances shall compute the
61	61	retail pharmacy's minimum daily buprenorphine stocking
62	62	requirement by determining the average amount of buprenorphine
63	63	.229397.6 underscored material = new
64	64	[bracketed material] = delete
65	65	1
66	66	2
67	67	3
68	68	4
69	69	5
70	70	6
71	71	7
72	72	8
73	73	9
74	74	10
75	75	11
76	76	12
77	77	13
78	78	14
79	79	15
80	80	16
81	81	17
82	82	18
83	83	19
84	84	20
85	85	21
86	86	22
87	87	23
88	88	24
89	89	25
90	90	dispensed per day in the previous thirty days, rounding to the
91	91	nearest milligram. Each retail pharmacy shall maintain a stock
92	92	of buprenorphine sufficient to satisfy the minimum daily
93	93	buprenorphine stocking requirement, plus at least three
94	94	additional prescriptions for buprenorphine, including at least
95	95	one prescription for buprenorphine that is a buprenorphine
96	96	monoproduct and one prescription for buprenorphine that is a
97	97	buprenorphine-naloxone combination product. A retail pharmacy
98	98	that fails to satisfy the stocking requirements of this section
99	99	is not in violation of this section if the retail pharmacy
100	100	takes any of the following actions within three days of failing
101	101	to satisfy the stocking requirements:
102	102	(1) ordering a replacement stock of
103	103	buprenorphine sufficient to satisfy the stocking requirements
104	104	of this section; or
105	105	(2) requesting a wholesale drug distributor to
106	106	increase the retail pharmacy's allotment of buprenorphine, and:
107	107	(a) once the wholesale drug distributor
108	108	approves the request, ordering a replacement stock of
109	109	buprenorphine within three days of receiving the approval; or
110	110	(b) the wholesale drug distributor
111	111	denies the request.
112	112	B. A retail pharmacy shall maintain records of the
113	113	retail pharmacy's minimum daily buprenorphine stocking
114	114	requirements. Records shall be maintained for a period of at
115	115	.229397.6
116	116	- 2 - underscored material = new
117	117	[bracketed material] = delete
118	118	1
119	119	2
120	120	3
121	121	4
122	122	5
123	123	6
124	124	7
125	125	8
126	126	9
127	127	10
128	128	11
129	129	12
130	130	13
131	131	14
132	132	15
133	133	16
134	134	17
135	135	18
136	136	19
137	137	20
138	138	21
139	139	22
140	140	23
141	141	24
142	142	25
143	143	least three years from the date of the record and may be
144	144	inspected as required by authorized agents of the board.
145	145	C. A wholesale drug distributor shall report to the
146	146	board on a monthly basis, in a form and manner prescribed by
147	147	the board, each instance in which the wholesale drug
148	148	distributor:
149	149	(1) denied, in whole or in part, an order for
150	150	buprenorphine submitted by a retail pharmacy;
151	151	(2) delayed an order for buprenorphine
152	152	submitted by a retail pharmacy due to the retail pharmacy's
153	153	threshold of buprenorphine; or
154	154	(3) denied a request by a retail pharmacy to
155	155	increase the retail pharmacy's threshold of buprenorphine.
156	156	D. A report submitted by a wholesale drug
157	157	distributor pursuant to this subsection shall include:
158	158	(1) the name of the retail pharmacy affected;
159	159	(2) the date on which the retail pharmacy
160	160	submitted the order for buprenorphine or requested an increase
161	161	to the retail pharmacy's threshold of buprenorphine;
162	162	(3) the date on which the wholesale drug
163	163	distributor denied or delayed the retail pharmacy's order for
164	164	buprenorphine or denied the requested increase in the retail
165	165	pharmacy's threshold of buprenorphine;
166	166	(4) the reason the wholesale drug distributor
167	167	denied or delayed the retail pharmacy's order for buprenorphine
168	168	.229397.6
169	169	- 3 - underscored material = new
170	170	[bracketed material] = delete
171	171	1
172	172	2
173	173	3
174	174	4
175	175	5
176	176	6
177	177	7
178	178	8
179	179	9
180	180	10
181	181	11
182	182	12
183	183	13
184	184	14
185	185	15
186	186	16
187	187	17
188	188	18
189	189	19
190	190	20
191	191	21
192	192	22
193	193	23
194	194	24
195	195	25
196	196	or denied the requested increase in the retail pharmacy's
197	197	threshold of buprenorphine; and
198	198	(5) any other information required by the
199	199	board.
200	200	E. The board shall submit data gathered pursuant to
201	201	this section to the department of health. The department of
202	202	health shall analyze the data and publish a biannual report on
203	203	access to buprenorphine in retail pharmacies. The report shall
204	204	include:
205	205	(1) information on the frequency with which
206	206	each wholesale drug distributor:
207	207	(a) denied a retail pharmacy's order for
208	208	buprenorphine;
209	209	(b) delayed a retail pharmacy's order
210	210	for buprenorphine due to the retail pharmacy's threshold of
211	211	buprenorphine; or
212	212	(c) denied a retail pharmacy's requested
213	213	increase in the retail pharmacy's threshold of buprenorphine;
214	214	(2) aggregated data on the reasons reported by
215	215	wholesale drug distributors for denying a retail pharmacy's
216	216	order for buprenorphine or a request by a retail pharmacy to
217	217	increase the retail pharmacy's threshold of buprenorphine;
218	218	(3) a description of how denials or delays of
219	219	retail pharmacy orders for buprenorphine affected access to
220	220	buprenorphine;
221	221	.229397.6
222	222	- 4 - underscored material = new
223	223	[bracketed material] = delete
224	224	1
225	225	2
226	226	3
227	227	4
228	228	5
229	229	6
230	230	7
231	231	8
232	232	9
233	233	10
234	234	11
235	235	12
236	236	13
237	237	14
238	238	15
239	239	16
240	240	17
241	241	18
242	242	19
243	243	20
244	244	21
245	245	22
246	246	23
247	247	24
248	248	25
249	249	(4) a description of how denials of retail
250	250	pharmacy requests to increase their threshold of buprenorphine
251	251	affected access to buprenorphine;
252	252	(5) geographic and demographic disparities in
253	253	access to buprenorphine in retail pharmacies, to the extent the
254	254	data is available;
255	255	(6) the impact of insufficient access to
256	256	buprenorphine in retail pharmacies on initiation of and
257	257	retention in treatment for opioid use disorder, overdose
258	258	morbidity and mortality and other health outcomes associated
259	259	with substance use disorder; and
260	260	(7) any other relevant information.
261	261	F. Reports published pursuant to Subsection E of
262	262	this section shall comply with state and federal privacy and
263	263	confidentiality laws, rules and regulations.
264	264	G. The board may impose the following penalties on
265	265	retail pharmacies that violate this section:
266	266	(1) for a first or second violation, notice of
267	267	the violation that includes information on the requirements to
268	268	comply with this section; and
269	269	(2) for a third violation or any subsequent
270	270	violation within a thirty-six-month period following the
271	271	previous violation, a fine not to exceed two thousand five
272	272	hundred dollars ($2,500).
273	273	H. The board may impose the following penalties on
274	274	.229397.6
275	275	- 5 - underscored material = new
276	276	[bracketed material] = delete
277	277	1
278	278	2
279	279	3
280	280	4
281	281	5
282	282	6
283	283	7
284	284	8
285	285	9
286	286	10
287	287	11
288	288	12
289	289	13
290	290	14
291	291	15
292	292	16
293	293	17
294	294	18
295	295	19
296	296	20
297	297	21
298	298	22
299	299	23
300	300	24
301	301	25
302	302	wholesale drug distributors that violate this section:
303	303	(1) for a first violation, notice of the
304	304	violation that includes information on the requirements to
305	305	comply with this section; and
306	306	(2) for a second violation or any subsequent
307	307	violation within a thirty-six-month period following the
308	308	previous violation, a fine not to exceed ten thousand dollars
309	309	($10,000).
310	310	I. As used in this section:
311	311	(1) "buprenorphine" means the drug
312	312	buprenorphine, including any official, generic or chemical name
313	313	used to describe buprenorphine prescribed for the treatment of
314	314	opioid use disorder;
315	315	(2) "minimum daily buprenorphine stocking
316	316	requirement" means the average number of milligrams of
317	317	buprenorphine dispensed by a retail pharmacy per day over a
318	318	thirty-day period, in formulations, dosages and brand names
319	319	consistent with the prescriptions for buprenorphine dispensed
320	320	by the retail pharmacy during the thirty-day period;
321	321	(3) "prescription for buprenorphine" means
322	322	sufficient buprenorphine in tablet or film form to provide a
323	323	patient with twenty-four milligrams per day for two weeks;
324	324	(4) "retail pharmacy" means a pharmacy
325	325	physically located, and licensed to dispense drugs, in the
326	326	state; and
327	327	.229397.6
328	328	- 6 - underscored material = new
329	329	[bracketed material] = delete
330	330	1
331	331	2
332	332	3
333	333	4
334	334	5
335	335	6
336	336	7
337	337	8
338	338	9
339	339	10
340	340	11
341	341	12
342	342	13
343	343	14
344	344	15
345	345	16
346	346	17
347	347	18
348	348	19
349	349	20
350	350	21
351	351	22
352	352	23
353	353	24
354	354	25
355	355	(5) "wholesale drug distributor" means a
356	356	person licensed to engage in the wholesale distribution of
357	357	prescription drugs in the state."
358	358	- 7 -
359	359	.229397.6